Tri Chemical Laboratories (4369) Fundamentals 2026 — P/E 17.6x, Revenue Analysis | SniperIQ
Tri Chemical Laboratories (4369) is a JP-listed Basic Materials company in Chemicals - Specialty with a market capitalization of ¥108.5B, trading at ¥3340.00 on the JPX. This SniperIQ fundamentals page covers Tri Chemical Laboratories's valuation (P/E 17.6x, P/B 3.0x), profitability (net margin 24.8%), revenue (¥23.9B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Tri Chemical Laboratories's market cap?
Tri Chemical Laboratories (4369) has a market capitalization of approximately ¥108.5B, trading at ¥3340.00 on the JPX. Market cap moves with the live share price.
What is Tri Chemical Laboratories's P/E ratio?
Tri Chemical Laboratories's trailing twelve-month P/E ratio is 17.6x, with a price-to-book (P/B) of 3.0x. Valuation multiples are best compared with Basic Materials sector peers rather than read in isolation.
How profitable is Tri Chemical Laboratories?
Tri Chemical Laboratories runs a net profit margin of 24.8%, a gross margin of 37.6%, and an operating margin of 25.2%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Tri Chemical Laboratories generate?
Tri Chemical Laboratories reported revenue of ¥23.9B for fiscal year 2025, with net income of ¥5.5B and earnings per share (EPS) of 169.72. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Tri Chemical Laboratories pay a dividend?
Tri Chemical Laboratories offers a trailing dividend yield of about 1.0%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Tri Chemical Laboratories financially healthy?
Tri Chemical Laboratories carries a debt-to-equity ratio of 0.17x and a current ratio of 4.68x, with a market beta of 1.58. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Tri Chemical Laboratories a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Tri Chemical Laboratories (4369) the key facts are: market cap ¥108.5B, P/E 17.6x, revenue ¥23.9B, 52-week range 2455-4455. Weigh valuation, profitability, growth, and balance-sheet strength against Basic Materials peers and form your own view.
Track Tri Chemical Laboratories's full fundamentals live
Get Tri Chemical Laboratories's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.